Nobel Prize 2026: How an Alga Gave Neuroscience a Light Switch

Put a few green algae in a petri dish, switch on a lamp beside it, and wait. Slowly the green drifts toward the light, because each cell steers by a tiny orange dot on its surface that works like a primitive eye. For decades this was a neat curiosity of plant biology. On 5 October 2026, it became the opening chapter of a Nobel Prize.

The prize, in Physiology or Medicine, honours three scientists whose work began with a plain question: how can a single cell react to light so fast? It is one of the stranger journeys in modern science, from a speck of green algae to the deepest questions about memory, emotion and behaviour.

In short. The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics. Hegemann and Nagel found channelrhodopsin, a light-gated channel in a single-celled alga. Deisseroth made it work in neurons and then in living animals, so researchers can now test which cells cause which behaviours. Clinical use, such as restoring sight, is still at its first steps.

Who won the 2026 Nobel Prize in Physiology or Medicine?

The Nobel Assembly at Karolinska Institutet awarded the 2026 prize jointly to Karl Deisseroth, Peter Hegemann, and Georg Nagel "for their discoveries concerning light-gated ion channels and optogenetics." The 12 million Swedish kronor (about 1.2 million US dollars) is shared equally among the three.

What is optogenetics, and why did neuroscience need it?

Optogenetics is a method in which specific nerve cells are made light-sensitive through genetics, so they can be switched on or off with light in a living brain.

An adult human brain holds around 90 billion nerve cells, each linked to thousands of others. Cells that control entirely different functions can sit tightly intermingled, while a single cell's connections may stretch to a distant region. Twentieth-century methods could show which brain regions were involved in which functions, but they were blunt. They could not prove that one particular type of cell directly causes a feeling or a behaviour.

Francis Crick saw this limit early. A few decades after helping uncover the double helix, he imagined switching on just one type of cell while leaving its neighbours alone, and guessed that light would be the ideal signal because neurons fire so quickly. He admitted the idea seemed far-fetched at the time.

How did a single-celled alga lead to the discovery of channelrhodopsin?

Peter Hegemann's question about how a swimming alga reacts to light so quickly led, with Georg Nagel's help, to channelrhodopsin in the early 2000s.

Hegemann's hunch about the eyespot

Hegemann, who grew up in a family of doctors and was drawn to exploration and unknown territory, studied the alga Chlamydomonas and its eyespot. Using tiny electrodes, he recorded an electrical signal that appeared within a fraction of a millisecond of the light hitting it. In the human eye, the chain from light to electrical signal takes at least ten milliseconds, so the alga was far faster.

His hypothesis was that a single protein complex both captures the light and acts as an ion channel. Colleagues were sceptical, since no known channel responded to light by itself. The proteins were also hard to study, because they became unstable and easily damaged once pulled out of the eyespot.

Nagel and the frog eggs

Around the year 2000, Japanese researchers made sequences for thousands of Chlamydomonas genes publicly available, and Hegemann's group found two that resembled known light-capturing proteins. To test them, he turned to ion-channel expert Georg Nagel, whom he had first met at the Max Planck Institute of Biophysics in Frankfurt, where Nagel trained under Ernst Bamberg.

Nagel injected each gene into the eggs of the African clawed frog, which then produced the proteins in their outer membranes. The hunch held. The proteins were ion channels that opened in response to light, and they were named channelrhodopsin-1 and channelrhodopsin-2. Channelrhodopsin-2 reacted to blue light within about 0.2 milliseconds, and when the two scientists placed it in human kidney cells, those cells became light-sensitive too.

Why one protein matters: because the same molecule senses the light and forms the channel, the response is almost instant. That speed is what makes it usable for brain cells, whose signals are measured in milliseconds.

In 2003, Hegemann and Nagel published their results and suggested that channelrhodopsin-2 could be a powerful tool for creating electrical impulses in cells with light.

How did Karl Deisseroth turn channelrhodopsin into a switch for the brain?

Deisseroth put the algal protein inside neurons and showed that light could fire them on command. His route to that moment began in a medical clinic, not a plant laboratory.

Born in Boston in 1971 and drawn to both science and literature, Deisseroth trained as a doctor and at one point considered becoming a neurosurgeon. A spell in a psychiatric clinic changed his direction. He was struck by the suffering of patients with depression, autism and schizophrenia, and he began to ask why a person with depression finds joy so hard to feel.

He earned a PhD in neuroscience alongside his medical degree, but brain slices in petri dishes could not answer those questions. He needed to understand cells working inside a living brain.

Others were chasing the same dream, yet many feared wasting time and money on something that looked unrealistic. Deisseroth decided the risk was worth taking, because the treatments he could offer his patients were rarely effective and often caused debilitating side effects.

When he heard about channelrhodopsin-2, he did something wonderfully ordinary. He wrote to Georg Nagel and asked for the DNA.

He introduced the gene into rat neurons growing in dishes, worried that the delicate cells might be harmed by a foreign gene. The cells made the protein with no apparent problems. When his group shone blue light on them, they responded within milliseconds, and the signal passed on to other neurons. The 2005 paper, with Nagel among its authors, was a decisive milestone.

In 2006 the approach was named optogenetics. In 2007, two years after the cultured-neuron paper, his group used a thin optical fibre inserted through a small hole in the skull to activate motor-cortex neurons in living mice and control their whisker movement. Deisseroth later said the team had to solve many major problems, "but we stuck with it." He then shared the method with other researchers who saw its potential.

What has optogenetics revealed about the brain?

Optogenetics has moved neuroscience from watching the brain to testing it: researchers can now switch on a given cell type and see what behaviour follows.

Waking sleeping mice

In 2007, Deisseroth worked with colleagues to place the channelrhodopsin gene in a recently discovered type of nerve cell that they suspected controlled wakefulness. When light fell on those cells, sleeping mice woke up.

Reactivating a fear memory

In 2012, Xu Liu and Steve Ramirez in Susumu Tonegawa's laboratory, with Karl Deisseroth among the co-authors, went after something even more elusive, the physical trace of a memory. They genetically tagged brain cells in mice that were active while the animals learned to fear a situation. Later, in a neutral setting, they lit those same cells, and the mice froze in fear despite facing no danger. It showed that reactivating those cells was enough to trigger the memory.

How mouse parents care for their young

The method also shows that complex behaviours are built from separate parts. In mice, one circuit governs gathering the young into the nest, while a different one controls grooming them. Other researchers have used the same approach to find circuits for pain, social behaviour, thirst, feeding, reward and attention, and even cells that cause a fever when the immune system switches on.

Who else contributed to optogenetics?

Many scientists shaped the field, and Nobel rules cap a prize at three people. Gero Miesenböck and colleagues' 2002 work made neurons light-sensitive using a combination of fly proteins, Ernst Bamberg supervised Nagel and worked with him on channelrhodopsin, and Edward Boyden was first author of the 2005 rat-neuron paper. All six shared the 2013 Brain Prize for inventing and refining optogenetics.

Can optogenetics treat disease or restore vision?

Not yet as a routine treatment. Optogenetics is mainly a research tool used in animals, and the Nobel committee describes medical use as first steps.

Retinitis pigmentosa is a hereditary disease that destroys the eye's rods and cones. In clinical trials, gene therapy has made surviving retinal ganglion cells light-sensitive using a protein called ChrimsonR. In a 2021 case report, a patient achieved partial visual recovery and could locate, count and touch objects while wearing light-stimulating goggles.

This article is a science explainer and not medical advice. Anyone with a vision or hearing problem should speak to a qualified doctor.

What does the Nobel Prize mean for the future of neuroscience?

It confirms that causal control, not just observation, is now central to brain science. Nobel Committee chair Per Svenningsson said optogenetics lets scientists map the brain in a way that was once only a dream.

The human lesson may last longer. A hunch about an alga, a test in frog eggs and a short letter asking for a gene together gave neuroscience its switch, and none of it began in the brain.

Sources and further reading

• Nobel Assembly at Karolinska Institutet, press release, 5 October 2026: https://www.nobelprize.org/prizes/medicine/2026/press-release/
• Nobel Prize, Popular information, "A light-sensitive algal protein energised neuroscience": https://www.nobelprize.org/prizes/medicine/2026/popular-information/
• Nobel Prize, Scientific background, "Optogenetics. Discovery of a neuronal switch": https://www.nobelprize.org/prizes/medicine/2026/advanced-information/
• Reuters report on the announcement, including Deisseroth's and Hegemann's backgrounds: https://www.timeslive.co.za/news/sci-tech/2026-10-05-german-and-us-neuroscientists-win-nobel-medicine-prize/
• Xinhua explainer, on the number of neurons and the retinal disease angle: https://www.thestar.com.my/news/world/2026/10/06/explainer-why-2026-nobel-prize-in-physiology-or-medicine-awards-optogenetics
• DPA report with Karl Deisseroth's reaction: https://www.qatar-tribune.com/article/257673/world/german-duo-us-scientist-win-nobel-medicine-prize-for-brain-research/amp
• STAT News coverage with comments from Karl Deisseroth: https://www.statnews.com/?p=1527905
• Ophthalmology Times, on the retinal disease angle: https://www.ophthalmologytimes.com/view/2026-nobel-prize-in-physiology-or-medicine-awarded-for-optogenetics-discovery
• Laser Focus World, on the 2013 Brain Prize for optogenetics: https://laserfocusworld.com/biooptics/bioscience/neuroscience/article/14191857/six-optogenetics-scientists-share-13m-brain-research-prize